Communiqués JanOne Inc.

Actions

JAN

US47089W1045

Temps réel estimé Cboe BZX Autres places de cotation 21:47:59 28/06/2024			Varia. 5j.	Varia. 1 janv.
2,275 ^USD	+3,88%		-0,88%	+305,41%

16/05	JanOne finalise l'acquisition de la société de technologie financière blockchain -- Les actions chutent après les heures d'ouverture	MT
15/05	JanOne Inc. (NasdaqCM:JAN) a conclu l'acquisition de Alt 5 Sigma Inc.	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma	26/06	AQ
ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORM	25/06	AQ
JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024	13/06	AQ
ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation Market	11/06	PR
JanOne Inc. added to the Russell Microcap® Index	03/06	PR
ALT 5 Sigma, a wholly-owned subsidiary of JanOne to Present at the iFX Expo, the World's largest online trading conference and tradeshow	28/05	PR
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech	16/05	PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider	13/05	PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider	10/05	PR
JanOne Regains Compliance with Nasdaq's Listing Requirements	15/03	PR
JanOne to Present at the Dawson James 8th Annual Investment Conference	21/09/23	PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference	31/08/23	PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain	29/08/23	PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	28/08/23	AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting	25/08/23	PR
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules	22/08/23	PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting	21/08/23	AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules	21/08/23	AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules	19/08/23	PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting	18/08/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués JanOne Inc.

Actions

JAN

US47089W1045

Communiqués

Filtres